Skip to content

Multicenter Bone and Joint Health Study

Multicenter Osteoarthritis Study (MOST) Second Renewal

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03033238
Acronym
MOST
Enrollment
4185
Registered
2017-01-26
Start date
2003-01-31
Completion date
2020-12-31
Last updated
2021-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis,Knee

Brief summary

The purpose of this study is to investigate opportunities for prevention and treatment of knee osteoarthritis (OA) by evaluating potentially modifiable risk factors for disease and poor pain and physical function outcomes especially among those with early or mild knee symptoms. The goal of the study is to find novel strategies to prevent disease at an early stage and to limit the impact of disease once it has occurred.

Detailed description

MOST study participants in the Existing Cohort (3,026 subjects) were enrolled in the original study in 2003-2005. Surviving Existing Cohort participants without end-stage knee osteoarthritis will be asked to participate in the 144-, 152-, 160- and 168-month follow-up contacts. In addition, in 2016-2018 the cohort will be enriched by the recruitment of an additional 1,500 New Cohort participants with early or mild knee symptoms. The goal of the study is to find novel strategies to prevent disease at an early stage.

Interventions

None listed

Sponsors

University of Iowa
CollaboratorOTHER
University of Alabama at Birmingham
CollaboratorOTHER
Boston University
CollaboratorOTHER
National Institute on Aging (NIA)
CollaboratorNIH
University of California, San Francisco
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
45 Years to 79 Years
Healthy volunteers
Yes

Inclusion criteria

for New Cohort Participants: * Age 45 to 69 Years (Adult, Senior) * Males and Females * Healthy Volunteers * Community-based Sample

Exclusion criteria

for New Cohort Participants: * Rheumatoid or inflammatory arthritis (based on self-report and use of medications specific to these conditions) * Serious health condition e.g., end-stage renal disease, etc. that would likely limit follow-up to less than 2-3 years * Plan to relocate out of geographic region in next 3 years * Not able to walk without the aid of a person or assistive device * Knee joint replacement surgery in either knee * Neither knee fits in the MRI knee coil (determined during Screening Visit). * Not competent to give informed consent * Advanced structural tibiofemoral or patellofemoral knee OA disease (KL grade 3 or 4) in either knee (Determined by Knee X-ray Screening)

Design outcomes

Primary

MeasureTime frameDescription
Worsening knee painChange from baseline (144-month) at ≥2 follow-up contacts (152-, 160-, 168-month follow-up contacts)Worsening knee pain defined as reaching minimally clinically important difference (MCID) for worsening on the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain questionnaire
Incident cartilage loss on MRIChange from baseline (144-month) at 168-month follow-up contactIncidence of cartilage loss on MRI extending to the bone
Function lossChange from baseline (144-month) at ≥2 follow-up contacts (152-, 160-, 168-month follow-up contacts)Defined as minimally clinically important difference (MCID) for worsening on the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) function questionnaire

Secondary

MeasureTime frameDescription
New onset knee bucklingChange from baseline (144-month) at ≥1 follow-up contact (152-, 160-, 168-month follow-up contacts)Self-report
Onset of constant knee painChange from baseline (144-month) at ≥2 follow-up contacts (152-, 160-, 168-month follow-up contacts)Self- report
New repeated fallsChange from baseline (144-month) at ≥1 follow-up contact (152-, 160-, 168-month follow-up contacts)Self-report
Worsening on MRIChange from baseline (144-month) at 168-month follow-up contactWorsening cartilage scores, bone marrow lesion, or meniscal damage
Worsening on X-rayChange from baseline (144-month) at 168-month follow-up contactIncreased Kellgren-Lawrence (KL) grade score, new KL grade 2 score, or semi-quantitative joint space loss in any compartment

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026